These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 10395470)
1. Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha. Newton RC; Decicco CP J Med Chem; 1999 Jul; 42(13):2295-314. PubMed ID: 10395470 [No Abstract] [Full Text] [Related]
2. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha. Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599 [TBL] [Abstract][Full Text] [Related]
3. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278 [TBL] [Abstract][Full Text] [Related]
4. Cholera toxin induces tumor necrosis factor alpha production in human monocytes. Yan Z; Yang DC; Jett M Mol Cell Biol Res Commun; 1999 Aug; 2(2):124-30. PubMed ID: 10542136 [TBL] [Abstract][Full Text] [Related]
5. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. Gertsch J; Schoop R; Kuenzle U; Suter A FEBS Lett; 2004 Nov; 577(3):563-9. PubMed ID: 15556647 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factors: developments during the last decade. Aggarwal BB; Natarajan K Eur Cytokine Netw; 1996; 7(2):93-124. PubMed ID: 8688493 [No Abstract] [Full Text] [Related]
7. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Jäättelä M Lab Invest; 1991 Jun; 64(6):724-42. PubMed ID: 1646350 [No Abstract] [Full Text] [Related]
9. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition. Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). Sutheesophon K; Nishimura N; Kobayashi Y; Furukawa Y; Kawano M; Itoh K; Kano Y; Ishii H; Furukawa Y J Cell Physiol; 2005 May; 203(2):387-97. PubMed ID: 15515013 [TBL] [Abstract][Full Text] [Related]
11. Involvement of PKA, PKC, and Ca2+ in LPS-activated expression of the chicken lysozyme gene. Regenhard P; Goethe R; Phi-van L J Leukoc Biol; 2001 Apr; 69(4):651-8. PubMed ID: 11310853 [TBL] [Abstract][Full Text] [Related]
12. cAMP protects neutrophils against TNF-alpha-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac). Krakstad C; Christensen AE; Døskeland SO J Leukoc Biol; 2004 Sep; 76(3):641-7. PubMed ID: 15178699 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line. Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548 [TBL] [Abstract][Full Text] [Related]
14. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP and cyclic GMP suppress TNFalpha-induced hepatocyte apoptosis by inhibiting FADD up-regulation via a protein kinase A-dependent pathway. Wang Y; Kim PK; Peng X; Loughran P; Vodovotz Y; Zhang B; Billiar TR Apoptosis; 2006 Mar; 11(3):441-51. PubMed ID: 16538385 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Zhang M; Qian J; Xing X; Kong FM; Zhao L; Chen M; Lawrence TS Clin Cancer Res; 2008 Mar; 14(6):1868-76. PubMed ID: 18347190 [TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Tselepis C; Perry I; Dawson C; Hardy R; Darnton SJ; McConkey C; Stuart RC; Wright N; Harrison R; Jankowski JA Oncogene; 2002 Sep; 21(39):6071-81. PubMed ID: 12203119 [TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha therapies: the next generation. Palladino MA; Bahjat FR; Theodorakis EA; Moldawer LL Nat Rev Drug Discov; 2003 Sep; 2(9):736-46. PubMed ID: 12951580 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation. Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]